UK markets closed

CVAC Jan 2024 55.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.00000.0000 (0.00%)
As of 11:50AM EDT. Market open.
Full screen
Previous close2.0000
Expiry date2024-01-19
Day's range2.0000 - 2.0000
Contract rangeN/A
Open interest8
  • Motley Fool

    Why CureVac Stock Plunged Today

    Shares of CureVac (NASDAQ: CVAC) were down 9.1% as of 2:45 p.m. ET Thursday after a German court temporarily suspended the biopharmaceutical company's patent trial against BioNTech (NASDAQ: BNTX). CureVac previously failed to develop a successful COVID-19 vaccine during the pandemic, opting instead to focus on potential second-generation vaccines in partnership with GlaxoSmithKline. BioNTech, by contrast, generated tens of billions of dollars in annual revenue from its successful mRNA vaccines developed in partnership with Pfizer.

  • Simply Wall St.

    CureVac N.V. (NASDAQ:CVAC) Analysts Just Trimmed Their Revenue Forecasts By 19%

    Today is shaping up negative for CureVac N.V. ( NASDAQ:CVAC ) shareholders, with the analysts delivering a substantial...

  • Simply Wall St.

    Further weakness as CureVac (NASDAQ:CVAC) drops 9.7% this week, taking one-year losses to 40%

    The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...